Faaborg Pharma - IP ApS: Financial statements 2024
CVR: 43517252
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Faaborg Pharma - IP ApS (CVR 43517252) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -247,665 and a net result of DKK -895,356. Equity in the 2024 report amounted to DKK -1,612,862.
- Gross Profit
- DKK -247,665
- Profit/Loss
- DKK -895,356
- Equity
- DKK -1,612,862
- Total Assets
- DKK 2,899,401
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Faaborg Pharma - IP ApS has published its interim report for the period September 12, 2022 – December 31, 2023.
About Faaborg Pharma - IP ApS
Faaborg Pharma - IP ApS is a Danish company of the type Anpartsselskab based in Faaborg, founded in 2022. The company is registered under the industry Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker. The management consists of Jan Knudsen. The board consists of Claus Wædeled (chair), Birk Simon Maldonado Andersen and Jan Knudsen. The company is owned by Faaborg Løve Produkter Holding I ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 75,860 and a net result of DKK -678,796 compared with DKK -895,356 the year before. Equity in the 2025 report amounted to DKK -2,291,658.